CORBUS PHARMACEUTICALS HOLDINGS, INC. 4,650,000 Shares of Common Stock (par value $0.0001 per share) Underwriting AgreementUnderwriting Agreement • October 24th, 2017 • Corbus Pharmaceuticals Holdings, Inc. • Pharmaceutical preparations • New York
Corbus Pharmaceuticals Holdings, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom Cantor Fitzgerald & Co. is acting as representative (the “Representative”), an aggregate of 4,650,000 shares (the “Underwritten Shares”) of Common Stock, par value $0.0001 per share, of the Company (“Common Stock”) and, at the option of the Underwriters, up to an additional 697,500 shares of Common Stock (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares”. The shares of Common Stock to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock”.
